More clinical trials are still ongoing regarding the use of monoclonal CD40 antibodies for the treatment of autoimmune diseases like Chron ́s disease (Kasran et al., 2005) or systemic lupus erythematosus (Perper et al., 2019). Here, CD40 is linked to autoimmune disease.